These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34990909)

  • 21. A meta-analysis of MSI frequency and race in colorectal cancer.
    Ashktorab H; Ahuja S; Kannan L; Llor X; Ellis NA; Xicola RM; Laiyemo AO; Carethers JM; Brim H; Nouraie M
    Oncotarget; 2016 Apr; 7(23):34546-57. PubMed ID: 27120810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States.
    Rahman R; Schmaltz C; Jackson CS; Simoes EJ; Jackson-Thompson J; Ibdah JA
    Cancer Med; 2015 Dec; 4(12):1863-70. PubMed ID: 26471963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiorespiratory Fitness and Exercise Training in African Americans.
    Swift DL; Johannsen NM; Earnest CP; Newton RL; McGee JE; Church TS
    Prog Cardiovasc Dis; 2017; 60(1):96-102. PubMed ID: 28606473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A decade of improved access to screening is associated with fewer colorectal cancer deaths in African Americans: a single-center retrospective study.
    Siba Y; Culpepper-Morgan J; Schechter M; Alatevi E; Jallow S; Onaghise J; Sey A; Ozick L; Sabbagh R
    Ann Gastroenterol; 2017; 30(5):518-525. PubMed ID: 28845107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of socioeconomic status and treatment disparities in colorectal cancer survival.
    Le H; Ziogas A; Lipkin SM; Zell JA
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1950-62. PubMed ID: 18708384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial Disparities in Colorectal Carcinoma Incidence, Severity and Survival Times Over 10 Years: A Retrospective Single Center Study.
    Arshad HM; Tetangco E; Shah N; Kabir C; Raddawi H
    J Clin Med Res; 2016 Nov; 8(11):777-786. PubMed ID: 27738478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential therapeutic actions of melatonin in colorectal cancer.
    Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
    Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin inhibits proliferation and viability and promotes apoptosis in colorectal cancer cells via upregulation of the microRNA-34a/449a cluster.
    Ji G; Zhou W; Li X; Du J; Li X; Hao H
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Old
    Syed AR; Thakkar P; Horne ZD; Abdul-Baki H; Kochhar G; Farah K; Thakkar S
    World J Gastrointest Oncol; 2019 Nov; 11(11):1011-1020. PubMed ID: 31798781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
    Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
    Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer.
    Francescangeli F; De Angelis ML; Zeuner A
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31816977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and risk factors of colorectal cancer in China.
    Yang Y; Han Z; Li X; Huang A; Shi J; Gu J
    Chin J Cancer Res; 2020 Dec; 32(6):729-741. PubMed ID: 33446996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with racial/ethnic differences in colorectal cancer screening.
    Shokar NK; Carlson CA; Weller SC
    J Am Board Fam Med; 2008; 21(5):414-26. PubMed ID: 18772296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies.
    Hull R; Francies FZ; Oyomno M; Dlamini Z
    Cancer Manag Res; 2020; 12():9869-9882. PubMed ID: 33116845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant DNA Methylation: Implications in Racial Health Disparity.
    Wang X; Ji P; Zhang Y; LaComb JF; Tian X; Li E; Williams JL
    PLoS One; 2016; 11(4):e0153125. PubMed ID: 27111221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity.
    Gomez SL; O'Malley CD; Stroup A; Shema SJ; Satariano WA
    BMC Cancer; 2007 Oct; 7():193. PubMed ID: 17939875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California.
    Cheng I; Witte JS; McClure LA; Shema SJ; Cockburn MG; John EM; Clarke CA
    Cancer Causes Control; 2009 Oct; 20(8):1431-40. PubMed ID: 19526319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer screening in African Americans: practice patterns in the United States. Are we doing enough?
    Waghray A; Jain A; Waghray N
    Gastroenterol Rep (Oxf); 2016 May; 4(2):136-40. PubMed ID: 27071411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal Trends in Geographic and Sociodemographic Disparities in Colorectal Cancer Among Medicare Patients, 1973-2010.
    Liang PS; Mayer JD; Wakefield J; Ko CW
    J Rural Health; 2017 Sep; 33(4):361-370. PubMed ID: 27578387
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.